日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Phase I Dose-Escalation Study of the Safety and Pharmacokinetics of AGS15E Monotherapy in Patients with Metastatic Urothelial Carcinoma

AGS15E单药治疗转移性尿路上皮癌患者的安全性和药代动力学I期剂量递增研究

Petrylak, Daniel P; Eigl, Bernhard J; George, Saby; Heath, Elisabeth I; Hotte, Sebastien J; Chism, David D; Nabell, Lisle M; Picus, Joel; Cheng, Susanna Y; Appleman, Leonard J; Sonpavde, Guru P; Morgans, Alicia K; Pourhosseini, Pourya; Wu, Ruishan; Standley, Laura; Croitoru, Ruslan; Yu, Evan Y

Interim Phase II Results Using Panitumumab-IRDye800CW during Transoral Robotic Surgery in Patients with Oropharyngeal Cancer

帕尼单抗-IRDye800CW联合经口机器人手术治疗口咽癌患者的II期临床试验中期结果

Stone, Logan D; Kasten, Benjamin B; Rao, Shilpa; Gonzalez, Manuel L; Stevens, Todd M; Lin, Diana; Carroll, William; Greene, Benjamin; Moore, Lindsay S; Fuson, Andrew; James, Sherin; Hartman, Yolanda E; McCammon, Susan; Panuganti, Bharat; Nabell, Lisle M; Li, Yufeng; Li, Mei; Bailey, Luke; Rosenthal, Eben L; Jeyarajan, Harishanker; Thomas, Carissa M; Warram, Jason M

Radiotherapy Plus Cisplatin With or Without Lapatinib for Non-Human Papillomavirus Head and Neck Carcinoma: A Phase 2 Randomized Clinical Trial

放疗联合顺铂(加或不加拉帕替尼)治疗非人乳头瘤病毒性头颈癌:一项 II 期随机临床试验

Wong, Stuart J; Torres-Saavedra, Pedro A; Saba, Nabil F; Shenouda, George; Bumpous, Jeffrey M; Wallace, Robert E; Chung, Christine H; El-Naggar, Adel K; Gwede, Clement K; Burtness, Barbara; Tennant, Paul A; Dunlap, Neal E; Redman, Rebecca; Stokes, William A; Rudra, Soumon; Mell, Loren K; Sacco, Assuntina G; Spencer, Sharon A; Nabell, Lisle; Yao, Min; Cury, Fabio L; Mitchell, Darrion L; Jones, Christopher U; Firat, Selim; Contessa, Joseph N; Galloway, Thomas; Currey, Adam; Harris, Jonathan; Curran, Walter J Jr; Le, Quynh-Thu

Intralesional SD-101 in Combination with Pembrolizumab in Anti-PD-1 Treatment-Naïve Head and Neck Squamous Cell Carcinoma: Results from a Multicenter, Phase II Trial

在未接受过抗PD-1治疗的头颈部鳞状细胞癌患者中,病灶内注射SD-101联合帕博利珠单抗的疗效:一项多中心II期试验的结果

Cohen, Ezra E W; Nabell, Lisle; Wong, Deborah J; Day, Terry; Daniels, Gregory A; Milhem, Mohammed; Deva, Sanjeev; Jameson, Michael; Guntinas-Lichius, Orlando; Almubarak, Mohammed; Strother, Matthew; Whitman, Eric; Chisamore, Michael; Obiozor, Cynthia; Bagulho, Teresa; Gomez-Romo, Jose; Guiducci, Cristiana; Janssen, Robert; Gamelin, Erick; Algazi, Alain P

Traditional risk factors and cancer-related factors associated with cardiovascular disease risk in head and neck cancer patients

传统危险因素和癌症相关因素与头颈癌患者心血管疾病风险相关

Mukherjee, Amrita; Wiener, Howard W; Griffin, Russell L; Lenneman, Carrie; Chatterjee, Arka; Nabell, Lisle M; Lewis, Cora E; Shrestha, Sadeep

Safety and Efficacy of Durvalumab With or Without Tremelimumab in Patients With PD-L1-Low/Negative Recurrent or Metastatic HNSCC: The Phase 2 CONDOR Randomized Clinical Trial

Durvalumab联合或不联合Tremelimumab治疗PD-L1低表达/阴性复发或转移性头颈部鳞状细胞癌患者的安全性和有效性:CONDOR II期随机临床试验

Siu, Lillian L; Even, Caroline; Mesía, Ricard; Remenar, Eva; Daste, Amaury; Delord, Jean-Pierre; Krauss, Jürgen; Saba, Nabil F; Nabell, Lisle; Ready, Neal E; Braña, Irene; Kotecki, Nuria; Zandberg, Dan P; Gilbert, Jill; Mehanna, Hisham; Bonomi, Marcelo; Jarkowski, Anthony; Melillo, Giovanni; Armstrong, Jon M; Wildsmith, Sophie; Fayette, Jérôme

First-Line Treatment of Widely Metastatic BRAF-Mutated Salivary Duct Carcinoma With Combined BRAF and MEK Inhibition

BRAF 和 MEK 抑制剂联合治疗广泛转移性 BRAF 突变型唾液导管癌的一线治疗

Lin, Victor T G; Nabell, Lisle M; Spencer, Sharon A; Carroll, William R; Harada, Shuko; Yang, Eddy S

LCCC 1025: a phase II study of everolimus, trastuzumab, and vinorelbine to treat progressive HER2-positive breast cancer brain metastases

LCCC 1025:一项评估依维莫司、曲妥珠单抗和长春瑞滨联合治疗进展性 HER2 阳性乳腺癌脑转移的 II 期研究

Van Swearingen, Amanda E D; Siegel, Marni B; Deal, Allison M; Sambade, Maria J; Hoyle, Alan; Hayes, D Neil; Jo, Heejoon; Little, Paul; Dees, Elizabeth Claire; Muss, Hyman; Jolly, Trevor; Zagar, Timothy M; Patel, Nirali; Miller, C Ryan; Parker, Joel S; Smith, J Keith; Fisher, Julie; Shah, Nikita; Nabell, Lisle; Nanda, Rita; Dillon, Patrick; Abramson, Vandana; Carey, Lisa A; Anders, Carey K

Implementation and utilization of the molecular tumor board to guide precision medicine

分子肿瘤委员会的实施和应用以指导精准医疗

Harada, Shuko; Arend, Rebecca; Dai, Qian; Levesque, Jessica A; Winokur, Thomas S; Guo, Rongjun; Heslin, Martin J; Nabell, Lisle; Nabors, L Burt; Limdi, Nita A; Roth, Kevin A; Partridge, Edward E; Siegal, Gene P; Yang, Eddy S

Phase I dose-escalating trial of Escherichia coli purine nucleoside phosphorylase and fludarabine gene therapy for advanced solid tumors

大肠杆菌嘌呤核苷磷酸化酶和氟达拉滨基因疗法治疗晚期实体瘤的I期剂量递增试验

Rosenthal, E L; Chung, T K; Parker, W B; Allan, P W; Clemons, L; Lowman, D; Hong, J; Hunt, F R; Richman, J; Conry, R M; Mannion, K; Carroll, W R; Nabell, L; Sorscher, E J